Co-Diagnostics Inc CODX

NAS: CODX | ISIN: US1897631057   30/04/2025
0,351 USD (-2,01%)
(-2,01%)   30/04/2025

27 maart 2025 · Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results · Persbericht

13 maart 2025 · Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast · Persbericht

6 maart 2025 · Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit · Persbericht

3 maart 2025 · Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 · Persbericht

5 september 2024 · Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test · Persbericht

15 augustus 2024 · Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. · Persbericht

8 augustus 2024 · Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results · Persbericht

29 juli 2024 · Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago · Persbericht

25 juli 2024 · Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast · Persbericht

2 juli 2024 · Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States · Persbericht

18 juni 2024 · Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 · Persbericht

14 juni 2024 · Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform · Persbericht

9 mei 2024 · Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results · Persbericht

25 april 2024 · Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast · Persbericht

24 april 2024 · Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan · Persbericht

12 april 2024 · Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event · Persbericht

4 april 2024 · Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions · Persbericht

21 maart 2024 · Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address · Persbericht

18 maart 2024 · Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England · Persbericht

14 maart 2024 · Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results · Persbericht

Mijn selecties